Back to all studiesUnknownNCT01008098
Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With PTSD
Medication studyAges 18–65South Korea
The study in practiceUnderstand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Activities
- Medication described in the protocol
- Compensation
- Payment and expense reimbursement have not been verified.
What to know before participating
A point to clarifyThis summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Study clarityThings to check before joining
Study start dateNovember 2008
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 26
- Sponsor
- Seoul National University Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- South Korea
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01008098
- Official title
Show the full official title
Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With Posttraumatic Stress Disorder
Need help understanding this study?
Leave your email and we’ll get in touch to discuss your questions and possible next steps.
A listed location does not confirm current availability.
FAQQuestions about this study
Who is behind this study?
The study sponsor is Seoul National University Hospital, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including escitalopram (lexapro).
Who can participate?
Listed age limits: 18 years to 65 years.
Explore other studiesWant to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me